Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer ’s Disease Using Immunomagnetic Reduction

ConclusionBased on this study, a single assay of A β1 –40, A β1 –42 and T-Tau, respectively, provides reliable results in terms of the measurement of that plasma biomarker.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: Alzheimer's | Brain | Neurology | Study